Potential Prion Involvement in Long COVID-19 Neuropathology, Including Behavior
- PMID: 36977809
- PMCID: PMC10047479
- DOI: 10.1007/s10571-023-01342-8
Potential Prion Involvement in Long COVID-19 Neuropathology, Including Behavior
Abstract
Prion' is a term used to describe a protein infectious particle responsible for several neurodegenerative diseases in mammals, e.g., Creutzfeldt-Jakob disease. The novelty is that it is protein based infectious agent not involving a nucleic acid genome as found in viruses and bacteria. Prion disorders exhibit, in part, incubation periods, neuronal loss, and induce abnormal folding of specific normal cellular proteins due to enhancing reactive oxygen species associated with mitochondria energy metabolism. These agents may also induce memory, personality and movement abnormalities as well as depression, confusion and disorientation. Interestingly, some of these behavioral changes also occur in COVID-19 and mechanistically include mitochondrial damage caused by SARS-CoV-2 and subsequenct production of reactive oxygen species. Taken together, we surmise, in part, long COVID may involve the induction of spontaneous prion emergence, especially in individuals susceptible to its origin may thus explain some of its manesfestions post-acute viral infection.
Keywords: COVID-19; Confusion; Depression; Long COVID; Mitochondria; Prion; Prion disorders; SARS-CoV-2.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Benz D, Cadet P, Mantione K, Zhu W, Stefano GB (2002) Tonal nitric oxide and health: a free radical and a scavenger of free radicals. Med Sci Monit 8(1):1–4 - PubMed
-
- Choi SI, Ju WK, Choi EK, Kim J, Lea HZ, Carp RI, Wisniewski HM, Kim YS (1998) Mitochondrial dysfunction induced by oxidative stress in the brains of hamsters infected with the 263 K scrapie agent. Acta Neuropathol 96(3):279–286. 10.1007/s004010050895 - PubMed
-
- Colini Baldeschi A, Zattoni M, Vanni S, Nikolic L, Ferracin C, La Sala G, Summa M, Bertorelli R, Bertozzi SM, Giachin G, Carloni P, Bolognesi ML, De Vivo M, Legname G (2022) Innovative non-PrP-targeted drug strategy designed to enhance prion clearance. J Med Chem 65(13):8998–9010. 10.1021/acs.jmedchem.2c00205 - PMC - PubMed
-
- De Armond SJ, Bouzamondo E (2002) Fundamentals of prion biology and diseases. Toxicology 181–182:9–16. 10.1016/s0300-483x(02)00249-4 - PubMed
-
- de la Torre JC, Stefano GB (2000) Evidence that Alzheimer’s disease is a microvascular disorder: the role of constitutive nitric oxide. Brain ResRev 34:119–136 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
